Varanasi: The Banaras Hindu University (BHU) wants to carry out a clinical trial of immunity-boosting ayurvedic drug 'Fifatrol' to check its efficacy in tackling the deadly COVID-19.
However, the proposal is yet to be approved, official sources said. According to BHU professor and principal investigator for the proposed project, Dr K N Dwivedi, the plan has been sent to a task force formed by the government for scientific validation of Ayurveda and traditional medicinal formulas through research institutions in tackling coronavirus.
The inter-disciplinary AYUSH Research and Development Task Force has members from the Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR) and also AYUSH practitioners and